We invite you to attend Bioperfectus 2nd Global Distributors Conference

Company news


COVID-19 seems to pose a long-term battle for all the countries around the world, it is a must for bothBioperfectusand itsdistributorsto equip themselves with new skills and capabilities to cope with the post-pandemic era.


To navigate a healthier life, Bioperfectus is upgrading ourproductsandservicetocope with the fast-changing infectious disease diagnostic market. 


After successfully organizing Bioperfectus 1st Global Distributors Conference virtually, we are glad to bring together our latest progress and product information to present you Bioperfectus 2nd Global DistributorsConference.


CLICK HERE to register now!


Navigating a healthier life, we are waiting for you to board!


Bioperfectus Extraction Solutions, One-Stop to Satisfy Your Requirements

Nucleic acid extraction provides a foundation for many extensive research and applications (for example cloning, PCR analysis, and next-generation sequencing technology in the field of whole genome and transcriptome), and the obtained nucleic acid can be used in a variety of ways. Nucleic acid purification and quality assessment are important steps in experimental workflows, and the quality of nucleic acids can affect the performance in downstream reactions.


Client Story: G Company and Bioperfectus Success Story

Infectious diseases spread rapidly, and individuals with viruses can spread the infection to many other people in their community. Bioperfectus is still in a race against time and a guardian of humankind.


SAW-96, More Than a Nucleic Acid Extraction Workstation

Nowadays, emerging infectious diseases significantly threaten global public health and socioeconomic security and will change how people live. COVID-19 is a notable example. There might also have an outbreak of Monkeypox based on the current situation. When a disease outbreak occurs, PCR would be a suitable way to accurately identify the pathogen and detect it in the early stage.